Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Pharmacy Technicians

26 result(s)

  • Professional Competencies for Canadian Pharmacists at Entry to Practice (2007)

    FOR REFERENCE ONLY - This document is currently referenced in the Pharmacy Practice Skills and Knowledge Self-Assessment Tool as part of NAPRA’s Pharmacists’ Gateway Canada program. It remains available for reference purposes only.

  • Professional Competencies for Canadian Pharmacists at Entry to Practice (2014)

    Professional Competencies for Canadian Pharmacists at Entry to Practice is one of the documents that form the basis of the National Model Licensing Program for Pharmacists. It describes the entry-to-practice competencies required for initial licensing to practice as a pharmacist in Canada.

  • Professional Competencies for Canadian Pharmacy Technicians at Entry to Practice

    This document describes the entry-to-practice competency requirements for pharmacy technicians across Canada. Competencies are described as significant job-related knowledge, skills, abilities, attitudes and judgements required for competent performance by members of a profession. They provide…

  • Resources for Pharmacy Operators

    FOR REFERENCE ONLY - The material contained in this document was prepared by NAPRA in the late 1990s and has not been updated since that time. It is important to note that any reference to the “National Model Standards of Practice” does not correspond with the current model standards…

  • Supplemental Competencies on Injection

    The scope of practice for pharmacists is changing across the country to include a greater range of activities and services performed by licensed pharmacists. One such activity is the administration of drugs including multiple routes both parenteral and non parenteral.  NAPRA’s Supplemental …

  • Supplemental Standards of Practice for Schedule II and III Drugs

    This document establishes the supplemental standards of practice for the pharmacist when consulting on the use of medications that are listed in the National Drug Schedules (NDS) as Schedule II and III drugs.